Velocity has completed more than 30 trials in Europe, where it has operated clinical research sites since 2020.


Supporting clinical trials in Europe

Velocity opened its first private dedicated research facility in High Wycombe in 2020. The site quickly established itself as a leading enroler. Soon after, Velocity opened facilities in North London, and has recently expanded into Germany with sites in Hamburg and Leipzig.

All Velocity sites are supported by experienced investigators and clinical staff who are versed in numerous therapeutic areas.

North London Skyline.
Research sites across Europe
Investigators across Europe
Clinical trials conducted in Europe

The right sites.
The right investigators.
The right partner for your trials.

All Velocity sites feature experienced principal investigators supported by well-trained research staff. Geographic dispersion also supports access to critical subpopulations. Above all, Velocity's sites are built to ensure world-class quality, scalability, and productivity.